Heterocyclisation of 2,5-diacetyl-3,4-Disubstituted-thieno[2,3-b]thiophene bis-Thiosemicarbazones leading to bis-Thiazoles and bis-1,3,4-Thiadiazoles as anti-Reast cancer agents

68Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this paper, the synthesis of bis-thiazoles and bis-1,3,4-thiadiazoles linked to a thienothiophene nucleus is described. The synthesis was achieved through interaction between 2,5-diacetylthieno[2,3-b]thiophene bis-thiosemicarbazones with a variety of hydrazonyl halides in a basic medium. All the synthesised compounds were characterised by IR, 1H NMR, 13C NMR and mass spectroscopic analyses. The newly synthesised compounds represent a variety of novel polyheteroatomic moieties containing nitrogen and sulfur. Most of the synthesised compounds were evaluated for their antitumour activity against the breast cancer MCF-7 cell line. The results revealed that four compounds are equipotent to tamoxifen (IC50 = 8.04 μg mL-1) with IC50 = 8.23, 8.26, 8.68 and 9.12 μg mL-1 respectively.

Cite

CITATION STYLE

APA

Gomha, S. M., Badrey, M. G., & Edrees, M. M. (2016). Heterocyclisation of 2,5-diacetyl-3,4-Disubstituted-thieno[2,3-b]thiophene bis-Thiosemicarbazones leading to bis-Thiazoles and bis-1,3,4-Thiadiazoles as anti-Reast cancer agents. Journal of Chemical Research, 40(2), 120–125. https://doi.org/10.3184/174751916X14537182696214

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free